JP Morgan Chase’s Satsuma Pharmaceuticals STSA Stock Holding History
Bought
Maintained
Sold
Other funds holding STSA
JP Morgan Chase's STSA Position: Q3 2022 in Review
JP Morgan Chase sold out of Satsuma Pharmaceuticals (STSA) in Q3 2022, closing a stake of 46,998 shares — an estimated $195K sold.
JP Morgan Chase first reported a position in STSA in Q4 2019 and held it in 8 quarters. The position peaked at $486K in Q2 2020. 41 funds tracked by Wall St. Rank hold STSA as of Q3 2022.
- JP Morgan Chase reported no remaining Satsuma Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- JP Morgan Chase sold 46,998 Satsuma Pharmaceuticals shares in Q3 2022, an estimated $195K.
- JP Morgan Chase first reported a position in Satsuma Pharmaceuticals in Q4 2019 and held it in 8 quarters.
- JP Morgan Chase's Satsuma Pharmaceuticals position peaked at $486K in Q2 2020.
- 41 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q3 2022.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.